BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36210135)

  • 1. Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction.
    Goyal P; Zainul O; Marshall D; Kitzman DW
    Cardiol Clin; 2022 Nov; 40(4):517-532. PubMed ID: 36210135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Warraich HJ; Kitzman DW; Whellan DJ; Duncan PW; Mentz RJ; Pastva AM; Nelson MB; Upadhya B; Reeves GR
    Circ Heart Fail; 2018 Nov; 11(11):e005254. PubMed ID: 30571197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with preserved ejection fraction: New approaches to diagnosis and management.
    Upadhya B; Kitzman DW
    Clin Cardiol; 2020 Feb; 43(2):145-155. PubMed ID: 31880340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
    Hamada T; Kubo T; Kawai K; Nakaoka Y; Yabe T; Furuno T; Yamada E; Kitaoka H;
    ESC Heart Fail; 2022 Jun; 9(3):1853-1863. PubMed ID: 35355441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction.
    Meng C; Chai K; Li YY; Luo Y; Wang H; Yang JF
    ESC Heart Fail; 2023 Apr; 10(2):1133-1143. PubMed ID: 36601690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
    Coats AJS; Butler J; Tsutsui H; Doehner W; Filippatos G; Ferreira JP; Böhm M; Chopra VK; Verma S; Nordaby M; Iwata T; Nitta D; Ponikowski P; Zannad F; Packer M; Anker SD
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):412-424. PubMed ID: 38158636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction.
    Upadhya B; Pisani B; Kitzman DW
    J Am Geriatr Soc; 2017 Nov; 65(11):2431-2440. PubMed ID: 29124734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study.
    Valdiviesso R; Amaral TF; Moreira E; Sousa-Santos AR; Fernandes M; Aguiar MJV; Martins S; Azevedo LF; Fernandes L; Silva-Cardoso J; Borges N
    BMC Cardiovasc Disord; 2023 Dec; 23(1):594. PubMed ID: 38053018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies.
    Omote K; Verbrugge FH; Borlaug BA
    Annu Rev Med; 2022 Jan; 73():321-337. PubMed ID: 34379445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction.
    Reeves GR; Whellan DJ; Patel MJ; O'Connor CM; Duncan P; Eggebeen JD; Morgan TM; Hewston LA; Pastva AM; Kitzman DW
    Am J Cardiol; 2016 Jun; 117(12):1953-8. PubMed ID: 27156830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches.
    Toth PP; Gauthier D
    Postgrad Med; 2021 Mar; 133(2):125-139. PubMed ID: 33283589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Nishino M; Egami Y; Kawanami S; Sugae H; Ukita K; Kawamura A; Nakamura H; Yasumoto K; Tsuda M; Okamoto N; Matsunaga-Lee Y; Yano M; Tanouchi J; Yamada T; Yasumura Y; Seo M; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
    Int J Cardiol; 2023 May; 378():55-63. PubMed ID: 36796493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.
    Navid P; Nguyen L; Jaber D; Zarzuela K; Musse M; Lu Wang M; Requijo T; Kozlov E; Masterson Creber RM; Hilmer SN; Lachs M; Goyal P
    J Am Geriatr Soc; 2021 Jul; 69(7):1948-1955. PubMed ID: 33978239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications.
    Pagel PS; Tawil JN; Boettcher BT; Izquierdo DA; Lazicki TJ; Crystal GJ; Freed JK
    J Cardiothorac Vasc Anesth; 2021 Jun; 35(6):1839-1859. PubMed ID: 32747202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction.
    Godfrey S; Peng Y; Lorusso N; Sulistio M; Mentz RJ; Pandey A; Warraich H
    Circ Heart Fail; 2023 Nov; 16(11):e010802. PubMed ID: 37869880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
    Tromp J; Shen L; Jhund PS; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Køber L; Swedberg K; Zile MR; Pitt B; Lam CSP; McMurray JJV
    J Am Coll Cardiol; 2019 Aug; 74(5):601-612. PubMed ID: 31370950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
    Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
    Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Goyal P; Yum B; Navid P; Chen L; Kim DH; Roh J; Jaeger BC; Levitan EB
    Am J Cardiol; 2021 Jun; 148():84-93. PubMed ID: 33667443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart failure with preserved ejection fraction (HFpEF)].
    Maeder MT; Buser M; Brenner R; Rickli H
    Ther Umsch; 2018 Sep; 75(3):161-169. PubMed ID: 30145974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical therapy in heart failure with preserved ejection fraction: A systematic review.
    Palau P; Núñez E; Domínguez E; Sanchis J; Núñez J
    Eur J Prev Cardiol; 2016 Jan; 23(1):4-13. PubMed ID: 25488549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.